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Cornman-Homonoff, Laurie Sylla, David Smith, and Frederick Altice.  Section of 
Infectious Diseases, Department of Internal Medicine, Yale University, School of 
Medicine, New Haven, CT.    
 
Background: Tens of millions of Americans enter jails annually.  The Centers for 
Disease Control and Prevention now recommends routine HIV testing in prisons and 
jails.  The logistics for performing routine HIV testing within jails, however, remains 
controversial.   
 
Specific Aims: 
1) To simulate and explore the feasibility of future implementation of a routine opt-
out HIV testing protocol using rapid testing methods in the often-chaotic jail 
setting. 
2) To evaluate the optimal time to perform routine HIV testing among inmates who 
are competent to consent to testing, in a manner that not only maximizes public 
health but also attends to the safety and health status of individual inmates. 
 
Methods: Two prospective, controlled trials of routine opt-out HIV testing were 
conducted among 323 newly incarcerated female inmates in Connecticut‟s only women‟s 
jail (during August and September 2007) and 298 newly incarcerated male inmates in an 
urban men‟s jail in New Haven, Connecticut (during March and April 2008).  Sequential 
entrants at both facilities were assigned to be offered routine opt-out HIV testing at one 
of three points after incarceration: immediate (same day), early (next day), or delayed (7 
days).  The primary outcome was the proportion of individuals in each group consenting 
to testing.  
 
Results: In the women‟s trial, routine opt-out HIV testing was significantly highest 
(73%) among the early testing group compared to 55% for immediate and 50% for 7 days 
post-entry groups. Other factors significantly (p=0.01) associated with being HIV tested 
were younger age and low likelihood of early release from jail based on bond value or 
type of charge for which women were arrested.  In the men‟s trial routine opt-out HIV 
testing was significantly higher for the early (53%: AOR=2.6; 95% CI=1.5 to 4.7) and 
immediate (45%: AOR=2.3; 95% CI=1.3 to 4.0) testing groups compared to the delayed 
(33%) testing group. The immediate and early testing groups, however, did not 
significantly differ (p=0.67).  In multivariate analyses, factors significantly associated 
with routine opt-out HIV testing were assignment to the „early‟ testing group (p=0.0003) 
and low (bond $5,000, immigration or federal charges or pre-sentencing >30 days) 
likelihood of early release (p=0.04). Two male subjects received preliminary positive 
results and one of them was subsequently confirmed HIV seropositive.   
 
Conclusions: In both correctional facilities, routine opt-out HIV testing in a jail setting 
was feasible, with highest rates of testing if performed within 24 hours of incarceration. 
Lower testing rates were seen with immediate testing, where there is a high prevalence of 
  
inability or unwillingness to test, and with delayed testing, where attrition from jail 
increases with each passing day.   
 
Trial Registration: ClinicalTrials.gov NCT00624247 
                             http://clinicaltrials.gov/ct2/show/NCT00624247 
 
 
 
 
The findings from these trials have been previously presented at the 46
th
 Annual Meeting 
of the Infectious Diseases Society of America in Washington, DC in October 2008. In 
addition, findings from both trials were previously published as companion pieces in 
PLoS One in November 2009. 
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Introduction  
Over 2.3 million people, or one in every 100 American adults, are incarcerated and 
their initial interface with the correctional system is usually via jail.[1-2]  The prevalence 
of HIV infection in the United States is also several-fold greater in correctional settings 
than in the general population.[3] One-quarter of HIV-infected individuals in the United 
States pass through a correctional facility every year and it is believed that anywhere 
from one third to one half of these persons are unaware of their HIV status.[4-6]  Jails 
and prisons thus serve as important sites for HIV testing and treatment.[5, 7-9]  
The Centers for Disease Control and Prevention (CDC) recently recommended 
implementing routine opt-out HIV testing in all healthcare settings, including jails,  
acknowledging that HIV testing guided by risk factor assessment alone misses many of 
those who are HIV-infected.[10]  As recently as 2007, however, HIV testing practices 
continued to be largely based on the pretesting probability that a patient had identifiable 
risk factors.[11] Yet, approximately 50% of individuals who enter correctional settings 
do not know their HIV status and many with HIV infection do not have traditional risk-
based behaviors for HIV.[9, 12]  Therefore, enhanced HIV testing strategies in 
correctional settings remain a high priority. 
The revised CDC recommendations call for routine testing in all clinical settings, 
the central goal being to maximize the number of persons who are aware of their HIV 
infection and receive care and prevention services.  According to the CDC guidelines for 
routine testing, “HIV-negative results may be conveyed without direct personal contact 
between the patient and the health-care provider.”  Only HIV positive results should be 
communicated confidentially through personal contact by a clinician, nurse, mid-level 
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practitioner, counselor, or other skilled staff.  Furthermore, the guidelines state that 
prevention counseling should not be required as a part of HIV screening programs in 
health-care settings. [10] 
Understanding the issues related to implementing routine opt-out HIV testing in 
jails presents both a challenge and an opportunity in correctional settings to expand 
access to HIV services to correctional inmates. [10, 13-14] Historically, performing HIV 
testing in jails has been difficult. Jails interact with a larger number of individuals at risk 
for HIV infection than do prisons; however, jails also pose unique logistical and health-
related constraints for implementing widespread HIV screening programs.  Jails differ 
from prisons in several important ways that impact HIV testing strategies:  1) jail 
populations have short periods of incarceration and high rates of turnover with many-fold 
greater admissions and discharges; 2) jails house individuals with higher rates of acute 
intoxication from psychoactive drugs, uncontrolled mental illness, and suicidal 
behavior;[15] and 3) the individuals who enter jails have higher recent risk behaviors for 
HIV than those in prisons.[16-17]  Given these considerations, jails have been less well-
equipped to implement screening, prevention, and treatment programs to address patients 
with or at risk for HIV/AIDS.  
Recent advances in testing diagnostics, however, have created promising 
opportunities for screening in jail settings. The development of the OraQuick rapid HIV-
1 antibody test, for example, allows for the prompt delivery of preliminary positive and 
definitively negative results within twenty minutes.[18]  Recent cost-benefit analyses also 
support expanded HIV screening in all settings, especially in sites where the prevalence 
of HIV exceeds 1%;[19-20] the prevalence of HIV in jails in the Northeast exceeds that 
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amount several-fold and would likely yield the highest number of unidentified HIV-
infected individuals.   
   Current HIV testing practices in U.S. jails are highly variable.  Nearly one-fifth of 
jails report no official HIV testing protocol, [21]  and as few as 21.6% of jail inmates 
were HIV tested after admission.[22]  Surveys conducted by the CDC and the National 
Institute of Justice, report that only 4% of jails provide HIV testing upon inmate request 
and only 2% offer routine HIV testing on admission; none of those surveyed mandated 
HIV testing of incoming inmates.[23]     
Experience with rapid HIV testing in jail settings is limited.[24-25]  To date, only 
two such studies have been published.  One study, conducted among female inmates 
during intake at the Cook County Jail, consisted of approaching detainees in the corner of 
a large room, in open view of security officers and fellow inmates, and offering them 
rapid HIV testing.  Among this group, 30% were found to be ineligible; however, 
ineligibility was not systematically defined.  Additionally, and perhaps as a result of 
requiring inmates to consent in a public setting, less than half of those approached were 
willing to accept testing.[24]  A more recent study was conducted at the Rhode Island 
Department of Corrections Jail, a facility where routine HIV testing has been in place for 
over 15 years.[25]  Although 95% of participants accepted rapid HIV testing, 87% 
reported they had been previously HIV tested at this facility during a prior incarceration.  
Moreover, the time after incarceration was not provided, suggesting that inmates may 
have been longer term inmates and we were not told how many were ineligible for HIV 
testing at all.  Given these circumstances, concerns remain whether the results of the 
Rhode Island study can be generalized to other correctional settings.  In addition to these 
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studies, the CDC has funded four Jail Demonstration Projects in Florida, Louisiana, New 
York and Wisconsin, encompassing more than 23 jails in those states.  The program, 
which offers voluntary rapid HIV testing based on referral, has conducted over 33,000 
tests and found that 1.1% of individuals were positive, 70% of whom were previously 
unknown cases of HIV.[26]  
None of the aforementioned studies adequately addresses the screening of inmates 
for psychological distress, intoxication, and withdrawal prior to conducting widespread 
HIV testing.    A major challenge to implementing a routine HIV testing protocol in jails 
is determining the optimal time to test, taking into account an inmate‟s ability to consent 
to testing and his or her level of psychological distress. Because the incarcerated 
experience high rates of suicidal behavior, mental illness, acute intoxication, and 
withdrawal, they might not be competent to consent to HIV testing or to receive a 
positive HIV test result, even though these same individuals might also be at highest risk 
for infection.[21, 25] Therefore, when choosing the appropriate time to screen inmates 
for HIV, testing must be performed in a manner that not only maximizes public health, 
but also attends to the safety and health status of individual inmates.  It is well 
documented that inmates are more likely to experience mental distress and present at a 
higher risk for committing suicide within the first 48 hours of incarceration.[15, 27-29]  
A ten-year study of deaths in the Chicago Cook County jail found that suicides were the 
third leading cause of death among inmates, following heart and cerebrovascular 
disease.[30]  In addition, studies of jail populations at time of admission show that acute 
symptoms of serious mental illnesses requiring treatment are present in about 6% of 
males and 15% of females at booking.[31-32] 
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Prisoners might be too distressed at their time of admission to consider the 
consequences of being HIV tested.  In particular, distressed individuals might not be 
prepared to receive a positive HIV test result.  Furthermore, recently incarcerated 
prisoners might be intoxicated or experiencing symptoms of withdrawal, thereby 
preventing them from providing informed consent.  The challenge with postponing 
testing is that many individuals experience very short stays in jail, with about 1/3 leaving 
within 48 hours, followed by further attrition daily for the first week.  Therefore, every 
day that testing is delayed a greater number of inmates will leave jail without being 
tested.  Although several authors have acknowledged the importance of screening jail 
inmates for mental status and suicide risk before conducting widespread HIV testing, no 
literature exists evaluating the tradeoffs between early versus late testing with regard to 
individual health needs and public health benefit. 
The CDC has identified several major issues that must be addressed when developing 
model routine HIV testing strategies in jails.  These include: 1) choosing the timing of 
testing after jail entry; 2) marketing and advertising of services; 3) manner in which 
testing is presented to inmates; 4) testing protocols; 5) methods of informing those tested 
of their results; 6) confidentiality of results; 7) HIV counseling associated with testing; 
and 8) administrative and implementation issues.[33]   
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Statement of Purpose, Specific Hypotheses, Specific Aims 
Statement of Purpose 
To evaluate the optimal time to conduct routine opt-out HIV testing of newly 
incarcerated male and female jail inmates in a manner that maximized the number of 
individuals capable of consenting and willing to be tested.  
  
Specific Hypotheses 
1. A higher proportion of inmates approached for testing the night of intake will be 
deemed incompetent to consent to testing (using the standardized MacArthur 
Competence Assessment Tool) compared to those inmates approached in the days 
after intake.  
2. A higher proportion of inmates approached for testing the night of intake will 
present at a higher risk for suicidal ideation and psychological distress (according 
to the nursing staff‟s mental health assessments and the standardized K6 
psychological distress scale) compared to those inmates approached in the days 
after intake. 
3. A higher proportion of inmates approached for testing the night of intake will not  
receive HIV testing (because they are either deemed incompetent or choose not to  
provide consent for testing) compared to inmates approached on subsequent days.  
4. A significant portion of individuals assigned to being approached for HIV testing 
on Day 7 will leave the facility prior to Day 7 and will miss the opportunity to be 
tested. 
5. Correctional medical and custodial staff will express resistance to implementing  
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widespread routine HIV testing in jail settings.  
 
Specific Aims 
1. To simulate and explore the feasibility of future implementation of a routine opt-
out HIV testing protocol using rapid testing methods in the often-chaotic jail 
setting; 
2. To determine the ability of subjects to pass a competency assessment in order to 
consent to routine HIV testing at varying times after entry into jail 
3. To examine the acceptability among jail inmates of a routine HIV testing protocol 
using rapid HIV testing methods; 
4. To evaluate the optimal time to perform routine HIV testing among inmates who 
are competent to consent to testing, in a manner that not only maximizes public 
health but also attends to the safety and health status of individual inmates. 
5. To assess the attitudes toward future widespread implementation of a routine 
rapid HIV testing protocol by correctional, medical, and custodial staff 
6. To assess the feasibility of implementing routine HIV testing in jails at different 
time points during and after entry processing from a systems operations 
perspective 
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Methods  
Ethics Statement 
These trials were approved by the Institutional Review Board at Yale University and 
by the Connecticut Department of Correction Research Committee.  
 
Design Overview 
These two prospective, controlled trials were conducted among female and male 
inmates in two Connecticut jails from 2007 to 2008.  Over a 5-week period starting 
August 22, 2007, all 323 consecutive, newly incarcerated female inmates at York 
Correctional Institution were offered routine opt-out HIV testing after being sequentially 
assigned to one of three study arms upon admission to the facility:  1) „immediate‟ 
(during a mandatory initial medical screen the night of admission); 2) „early‟ (during a 
required physical exam the following evening); or 3) „delayed‟ (7 days after arrival to the 
facility). The same study design was used for all 298 consecutive, newly incarcerated 
male inmates at New Haven Community Correctional Center from March 25, 2008 to 
April 16, 2008.  
Decisions about timing for routine opt-out HIV testing were based upon previous 
surveys of correctional and medical professionals as well as from experts in the field of 
HIV testing in correctional settings.  These three time points were chosen to coincide 
with other routine healthcare activities at the jail in order to simulate the future 
implementation of a routine opt-out HIV testing protocol.   
When designing the study protocol, review of the scientific literature suggested that 
not only do men and women have different attitudes toward HIV testing in jail or in 
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general, but they are also likely to present with different rates of mental illness and 
substance withdrawal that could potentially affect the primary outcome.  Additionally, 
the policymaking process is largely made independently for male and female jails.  
Therefore, the men‟s and women‟s trials were intended as separate studies with separate 
analyses.    Although the primary outcome was the same for both trials, the primary 
outcome was assessed independently for the male and female jails.   
 
Setting and Participants 
The women‟s trial was conducted at York Correctional Institution in Niantic, 
Connecticut, the state‟s sole correctional facility for women. Intake involves both 
sentenced and pre-trial detainees.   The average daily census is 1641 inmates.  Testing for 
pregnancy, opioids, tuberculosis and acute medical conditions is routinely conducted. 
Inmates maintained on or experiencing opioid withdrawal symptoms are provided a 
methadone taper.  The evening following admission, a routine physical examination, 
including Papanicolaou smear and phlebotomy, occurs in all new inmates remaining 
within the facility. [12] 
The men‟s trial was conducted at the New Haven Community Correctional Center 
(NHCCC) in New Haven, Connecticut, an urban men‟s jail that houses primarily 
unsentenced detainees as well as those serving sentences ≤1 year.   The facility‟s average 
daily census is 919 individuals.   
At both the men‟s and women‟s study sites, similar to other jails, a brief, standardized 
medical and psychiatric assessment is routinely conducted on all inmates, including 
medical, sexual, and drug-use histories immediately upon arrival. Voluntary HIV testing 
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is available by medical referral or by self-request and often involves being placed on a 
waiting list. Current policy in Connecticut requires that in the absence of an emergent 
clinical indication, inmates must be beyond the three month “window period” from their 
last HIV risk behavior to receive an HIV antibody test. Newly confirmed HIV positive 
test results are reported to the Connecticut Department of Public Health as part of the 
state‟s mandatory reporting system.  
As part of this study, all newly incarcerated inmates were sequentially approached for 
competency and HIV testing and sequentially assigned to one of the three study groups. 
Eligibility to be HIV tested required demonstration of competency by: 1) clinician-
confirmed ability to demonstrate knowledge of the risks, benefits, and consequences of 
HIV testing in accordance with the MacArthur Competence Assessment Tool for Clinical 
Research [MacCAT-CR][34]; and 2) no self-reported suicidal ideation or evidence of 
mental instability. 
 
Intervention 
For each testing group, the inmate was approached with the following scripted 
statement: “As part of your regular medical care, HIV testing can now be done using an 
oral swab that you swipe across your gums. You can receive your results after 20 
minutes.  Would you like to be tested at this time?” If the inmate responded affirmatively, 
he or she was instructed to self-administer the oral HIV test by the clinical staff in the 
„immediate‟ and „early‟ test groups as part of routine clinical activities in order to 
simulate how routine opt-out HIV testing would be performed if not embedded within a 
complicated research study.  On day 7, research personnel oversaw the verbal consent 
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and self-administration procedures using the same process.  All subjects were instructed 
that HIV results require minimal waiting.  Anyone not wanting to know HIV test results 
was not swabbed. If the inmate agreed to be swabbed and tested, he or she subsequently 
met with a research assistant who discussed two written informed consents – one for 
study participation and one for HIV testing (legislatively mandated). Inmates who 
initially agreed to be swabbed but refused to provide both written consents did not have 
their HIV swabs tested and these specimens were immediately discarded.  These 
individuals, along with anyone not wanting testing were informed voluntary HIV testing 
was available through self-referral from an HIV counselor.  Those who self-identified as 
being HIV-infected were not swabbed.  
   
Outcomes and Follow-up 
Oral swab testing was conducted onsite using the OraQuick ADVANCE

 rapid HIV-
1 antibody test [sensitivity: 99.3% (98.4-99.7), specificity: 99.8% (99.6-99.9)].[18, 35]  
The primary outcome, assessed independently for the male and female jails, was the 
proportion of individuals in each assigned group that provided verbal consent to be 
swabbed for HIV testing.  
 Individuals were not swabbed for HIV testing if they were physically not available 
(e.g., released from jail, at court, attorney visits, too ill), were deemed medically 
incompetent to provide consent, or opted out of HIV testing.  The primary outcome, 
using a public health perspective, was analyzed using an intention-to-treat (ITT) approach 
and included all inmates admitted to the jail during the study period, as assigned.  The 
intention-to-treat analysis assessed whether an inmate was swabbed, regardless of 
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whether he or she subsequently agreed to take part in the research protocol.  Any subject 
for whom swab results were missing was deemed “failure to swab” in the analysis; 
however, there were no missing data in the final database. A secondary outcome, to 
assess individual acceptability of HIV testing, was the proportion of inmates who agreed 
to HIV testing among those still under correctional supervision at the time that testing 
was offered.  
Pre-test counseling was not provided.  Subjects who received a preliminary positive 
test result were immediately referred for phlebotomy for confirmatory testing with 
Western blot.  Certified HIV counselors provided preliminary-positive post-test 
counseling and confirmatory results; study staff delivered negative results.   
As an additional secondary analysis, inmates deemed competent to receive testing 
who provided written consent were asked about previous HIV testing experiences, 
attitudes toward HIV testing in jail settings and were also administered a series of 
standardized instruments:  Clinical Opiate Withdrawal Scale [COWS], [36] Clinical 
Institute Withdrawal Assessment of Alcohol Scale [CIWA-Ar], [37] and the Kessler 6-
Item Psychological Distress Scale (K6).[38] 
To determine if the three testing groups in each trial differed with regard to social and 
demographic characteristics, the Connecticut Department of Correction (CTDOC) 
database was queried to abstract demographic characteristics [age and race (defined by 
CTDOC)], type of charge and bond value. No unique identifiers were provided.  Low 
likelihood of early release was defined as a bond value $5,000, sentencing > 30 days, 
immigration or federal charges, or no bond allowed.  High HIV-risk charges were 
considered to be any charges directly related to prostitution or drugs. 
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Statistical Analysis 
The primary outcome was the proportion of individuals in each testing group who 
were orally swabbed and provided verbal consent to receive rapid HIV testing.  Using 
two-sided Chi-Square tests for assessing three pair-wise differences between the different 
study arms and applying Bonferroni‟s correction (i.e., alpha=0.0166 for each 
comparison), we sought to collect 97 patients in each arm to achieve 80% power to detect 
a 22% difference between arms given a baseline uptake of 60%.   Comparisons of 
demographic, correctional and refusal characteristics were conducted using two-sided 
Chi-Square tests (alpha=0.05).   
After calculating the bivariate associations with the primary outcome, a multiple 
logistic regression model was developed to predict the likelihood of being swabbed using 
the available subject characteristic variables.  The Akaike information criterion (AIC) 
was used to assess model fit; lower AIC values indicate a better balance of parsimony 
and explanation of variance.  In conjunction with AIC, a p-value of 0.30 was used to 
enter and leave the model.  The optimal model was chosen as the convergence of the 
forward and backward models, with consideration of parsimony and plausibility. The 
two-sided Wald‟s test (alpha=0.05) was used to assess significance of each of the 
variables. All statistical analyses were conducted using SAS, version 9.1.3 (SAS 
Institute).  
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Results 
Women’s Trial 
The baseline characteristics of the study population for the women‟s trial are shown 
in Table 1.   During the study period, 323 newly incarcerated women were sequentially 
assigned to the following testing groups: „immediate‟ (N=108, the night of admission), 
„early‟ (N=108, the following evening), and „delayed‟ (N=107, 7 days later). The three 
study groups did not differ significantly with respect to any of the social and 
demographic characteristics assessed.   
The disposition of individuals approached for routine opt-out HIV testing in this trial 
is illustrated in Figure 1.  Overall, 192 (59%) of 323 inmates assigned to testing groups 
provided verbal consent to be swabbed for HIV testing.  For the primary outcome, 79 
(73%) of those offered „early‟ testing, received an HIV test, compared to 59 (55%) 
assigned to the „immediate‟ and 54 (50%) assigned to the „delayed‟ testing groups 
(Figure 2).  The early testing group was significantly more likely to be tested than both 
the immediate group (OR=2.3; 95% CI=1.3-4.0; p=0.007) and the delayed group 
(OR=2.7; 95% CI=1.5-4.7; p=0.0007).  The proportion swabbed in the immediate and 
delayed testing groups, however, did not differ (OR=1.2; 95% CI=0.7-2.0; p=0.54). To 
assess the individual acceptability of HIV testing, 268 subjects were physically present 
within the jail at the three time points when routine opt-out testing was made available 
(see Figure 2).  Acceptability was highest for the early testing group (N=79/91, 87%), 
compared to 76% (N=54/71) in the delayed and 56% (N=59/106) in the immediate 
testing group (p<0.05 for all comparisons).   
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Stratified by testing group, the reasons that inmates were not swabbed are depicted in 
Table 2. In the „immediate‟ group (N=108), 12 (11%) were medically incompetent to 
consent, compared with only 4 (4%) in each of the „early‟ (N=108) and „delayed‟  
(N=107) testing groups.  This difference was significant (OR=3.2; 95% CI=1.3-8.2; 
p=0.009; not depicted in Table 2).  In the „delayed‟ testing group, 36 (34%) did not 
appear for testing compared with 4 (4%) in the „immediate‟ and 17 (16%) in the „early‟ 
testing groups (OR comparing delayed to other: 4.7; 95% CI: 2.6-8.6; p=0.000001; not 
depicted in Table 2).   The most common reasons for failing to be available for testing 
included being released from the facility (either paid bond or released from court), 
appearing in court that day, or rarely, logistical barriers within the jail setting that 
prevented movement within the facility.  Among the 54 competent subjects who declined 
testing, 27 (54%) stated they did not perceive themselves at risk, 10 (19%) declared they 
were already HIV-infected (all were confirmed by medical record review), and 8 (15%) 
stated they were too tired, fearful of testing, or experiencing withdrawal. 
Figure 3 demonstrates the attrition-decay curve from  this jail expressed over time.  
The median duration of incarceration was 28 days; among the 323 subjects approached, 
90 (28%) were no longer incarcerated after 7 days, 118 (37%) after 14 days, and 247 
(76%) at 90 days after admission. The highest attrition rate was within the first 24 hours 
with 11% (n=34) leaving the facility during this time. These individuals, compared to 
those who were released at later times, trended toward having less opiate-positive urine 
test results (11% vs. 26%, p=0.06) and were less likely to be jailed for sex- or drug-
related charges (11% vs. 26%, p=0.06). They were also significantly less likely to have 
been previously incarcerated (43% vs. 66%, p=0.009).  Bivariate and multivariate 
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analyses were conducted to determine predictors associated with being swabbed for HIV 
testing (Table 3).  In the bivariate analysis, assignment to the „early‟ testing group, 
younger age, low-likelihood of release, high HIV-risk charges, and being Hispanic were 
associated with being swabbed for HIV testing.  In the multivariate analysis, assignment 
to the „early‟ testing group (p<0.001), younger age (p=0.01), and low likelihood of 
release (p=0.01) remained significantly associated with being swabbed for HIV testing.   
Of the 192 individuals who were swabbed, 151 (79%) provided written consent to 
complete the entire study. Two additional participants failed to pass the MacArthur 
Competence Assessment Tool, leaving 149 (79%) individuals eligible to be HIV tested.  
Of these, 147 (99%) were HIV-negative and two had a preliminary-positive test result; 
both results were false-positive after obtaining confirmatory Western Blot testing.  Thus, 
none of the 149 people tested were diagnosed as being HIV-infected.  Two negative test 
results (one from the „immediate‟ and one from the „early‟ testing groups) were not 
delivered due to the inmate having left the facility.   
Among the 149 subjects HIV-tested subjects that underwent standardized screening, 
11 (7%) exhibited moderate or severe opioid withdrawal symptoms: three (7%) from 
„immediate‟, eight (15%) from „early‟ group, and none from the „delayed‟ testing group.  
Ten (7%) individuals were deemed to have increased risk for alcohol withdrawal 
symptoms: three (7%) from „immediate‟, seven (13%) from „early‟, and none from the 
„delayed‟ testing group.  In addition, 50 (34%) of the 149 tested subjects had evidence of 
serious mental illness using the K6 psychological distress scale score: 11 (24%) from 
„immediate‟, 22 (42%) from „early‟, and 17 (33%) from the „delayed‟ testing group.  
Nearly all (89%) of these 149 subjects self-reported having been HIV tested previously, 
17 
 
but only 32% reported testing within the previous year.  The most recent HIV testing had 
occurred previously at a community organization (n=32, 21%), hospital (n=30, 20%), or 
correctional facility (n=29, 19%). 
 
Men’s Trial 
The baseline characteristics of the study population from the men‟s trial appear in 
Table 4.   The 298 newly incarcerated men were sequentially assigned to the following 
testing groups: „immediate‟ (N=103, the night of admission), „early‟ (N=98, the 
following evening), and „delayed‟ (N=97, 7 days later). The three study groups did not 
differ significantly with respect to any of the social and demographic characteristics 
assessed.   
The disposition of individuals approached for routine opt-out HIV testing in this trial 
is illustrated in Figure 4.  Overall, 130 (44%) of 298 inmates assigned to testing groups 
provided verbal consent to be swabbed for routine opt-out HIV testing.  Among those 
assigned to early testing, 52 (53%) accepted HIV testing versus 46 (45%) in the 
immediate and 32 (33%) for 7 days post-entry groups (Figure 5).  Compared to the 
delayed testing group, the early (OR=2.6; 95% CI=1.5 to 4.7; p =0.001) and immediate 
(OR=2.3; 95% CI=1.3 to 4.0; p = 0.01) testing groups were significantly more likely to 
be swabbed for HIV testing.  The immediate and early testing groups did not differ with 
regard to the primary outcome (p=0.67).  
There were differences between these two groups, however, in rates of acceptance 
among those actually physically available and medically competent to be approached for 
testing.  Of the 226 subjects that were physically present in the jail at each of the three 
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time points, acceptability was highest for the early testing group (N=52/74, 70%), 
compared to 45% (N=46/103) and 65% (N=32/49) in the immediate and delayed testing 
groups, respectively (see Figure 5).   
Stratified by testing group assignment, the reasons that inmates were not swabbed are 
depicted in Figure 6. In the immediate group, 5 (10% of those not swabbed in that group) 
were medically incompetent or did not have the capacity to consent, compared with none 
in the „early‟ and in the „delayed‟ testing groups.  In the „delayed‟ testing group, 48 (75% 
of those not tested) were no longer available for testing compared with none in the 
„immediate‟ and 24 (57% of those not tested) in the „early‟ groups.   Among the 77 
competent subjects who declined testing, 18 (23%) stated they were not interested in 
general, 15 (19%) did not perceive themselves to be at risk, 12 (16%) self-reported they 
were already HIV-infected (confirmed by medical record review), and 11 (14%) stated 
they were recently tested. 
Figure 7 demonstrates the time to release from the facility.  The median duration of 
incarceration at the facility was 34 days. Among the 298 subjects approached, 51 (17%) 
were released within the first 24 hours following admission, 81 (29%) were no longer 
incarcerated after 7 days, 107 (36%) after 14 days, and 142 (48%) were already released 
at 30 days. Individuals released within the first 24 hours following admission were less 
likely to have been incarcerated previously: 33 (65%) versus 211 (85%) (p=0.0005); the 
two groups did not vary on any other characteristics.   
Bivariate and multivariate analyses were conducted to determine predictors 
associated with being swabbed for routine opt-out HIV testing (Table 5).  In the bivariate 
analysis, assignment to the „immediate‟ or „early‟ testing groups was associated with 
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being swabbed for HIV testing.  In the multivariate analysis, however, only assignment to 
the „early‟ testing group (p=0.0003) and low likelihood of release (p=0.04) were 
significantly associated with being swabbed for HIV testing.   
Of the 144 individuals swabbed, 130 (90%) provided written consent to complete the 
entire study. Of these, 128 (98.5%) were HIV-negative and 2 (1.5%) had a preliminary 
positive test result; one was a false-positive and the other was confirmed using Western 
Blot testing. The one confirmed negative test occurred in the “immediate testing group”.  
Both individuals who tested preliminary positive were incarcerated at seven days and 
both received their confirmatory test results.   Based on the 12 confirmed individuals 
known to be HIV-infected and the one newly diagnosed subject in this study, the 
minimum HIV prevalence for this facility is 13/298 (4.4%).  
Among the 130 HIV-tested subjects who underwent standardized screening, 15 (12%) 
exhibited moderate or severe opioid withdrawal symptoms: 6 (13%) from „immediate‟, 4 
(8%) from „early‟ group, and 5 (16%) from the „delayed‟ testing group.  Only 3 (2%) 
individuals were deemed to have increased risk for alcohol withdrawal symptoms: 1 (2%) 
from „immediate‟, 2 (4%) from „early‟, and none from the „delayed‟ testing group.  In 
addition, 17 (13%) of the 130 tested subjects had evidence of serious mental illness using 
the K6 psychological distress scale score: 5 (11%) from „immediate‟, 9 (17%) from 
„early‟, and 3 (9%) from the „delayed‟ testing group.  
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Discussion 
To our knowledge, these represent the first prospective, controlled trials of routine 
opt-out HIV testing among inmates in any jail setting, a population that typically 
experiences high rates of psychological distress, rapid turnover, and both acute 
intoxication and withdrawal upon admission.  Previously, voluntary testing had been 
shown to have limited uptake rates; one multicenter study tested only 6% of ~550,000 jail 
detainees using voluntary testing methods. [39] One observational study conducted 
recently in a Rhode Island jail demonstrated markedly higher rates of acceptability of 
testing compared to that found in our study. [25]  The likely explanation for this 
difference is that mandatory HIV testing of prisoners has been in place in that state for 
nearly 20 years.  As such, nearly all (88%) subjects had previously been tested within that 
setting and the authors themselves suggest that HIV testing was no longer considered as 
an emotional or “charged” issue.  It can therefore be expected that acceptance of routine 
opt-out HIV testing will increase with time as the stigma and unfamiliarity with testing 
decreases among correctional staff and inmates. Additionally, a 4-site, CDC funded study 
demonstrated that rapid, voluntary HIV testing is feasible and identified many new 
people living with HIV. However, inmates often were tested days to weeks after 
incarceration, thereby potentially missing a large number of high risk individuals who 
were released prior to testing.[39]  New initiatives examining HIV testing strategies in 
jails are now underway.[26]   
Our results have two major public health implications.  First, routine opt-out HIV 
testing in jails is feasible, whether provided immediately upon intake or a day or week 
later.  The operational details of our program should provide guidance to jails 
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implementing routine opt-out HIV testing.  The characteristics of the available jail 
population vary over time such that delays in testing result both in reduced likelihood of 
testing but also missing the important opportunity to HIV test those who have never 
interfaced with the correctional environment.   
Second, our results suggest that testing within the first 24 hours after entry increases 
the number of individuals who receive HIV testing.  This is likely due to optimizing the 
balance between allowing time for psychological and medical stabilization of the 
individual and expeditiously providing testing prior to individuals leaving the facility.  
The magnitude of these effects are of significant public health importance, in that 73% of 
those women approached the evening after admission were swabbed for HIV testing, 
compared to 55% and 50% of those approached immediately or seven days post-entry, 
respectively.  This benefit was seen despite the fact that 11% of female inmates at this 
facility were released within the first 24 hours.   
Likewise, the primary outcome from the men‟s trial demonstrated that offering 
routine opt-out HIV testing to male inmates in this urban jail within the first 24 hours of 
admission resulted in the highest likelihood of being HIV tested (53%).  This suggests 
that routine opt-out HIV testing in jails should be offered as early in the intake process as 
possible.  To balance the competing factors of risk of release with inmate willingness to 
accept testing, it may be beneficial to offer routine opt-out HIV testing at intake and 
again at a subsequent medical appointment within 24 hours if the inmate is not tested the 
night of intake.  
The proportion of individuals choosing to opt out of testing the night of admission 
was high in both the women‟s and men‟s studies (32% and 50%, respectively).  Inmates 
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in both trials were also considerably more willing to accept testing when offered the day 
after entry.  Of the 268 women physically present in the facility at the time they were 
offered, 87% of those approached the evening after admission verbally consented to 
testing, compared to 56% and 75% of those in the immediate and delayed testing groups, 
respectively.  Similarly, in the men‟s trial, among inmates physically present in the jail at 
the time of testing, 55% of those approached in the immediate group opted out, versus 
30% in the early group.  The attrition rate due to inmates quickly bonding out, however, 
resulted in the equalization of swabbing rates between these two groups. In contrast to the 
women‟s jail, the trial among male inmates was conducted at an urban facility with more 
daily admissions and a higher rate of release within the first twenty-four hours.  These 
dynamics of increased attrition in the men‟s jail may account for the lost benefit of 
waiting until the day following entry to maximize uptake of HIV testing.   
Testing inmates on the day of incarceration may be less optimal because these 
individuals are distraught from being arrested and tired from remaining in court or in a 
holding cell all day.  The substantial increase in willingness to test 24 hours after 
admission may reflect acceptance of being incarcerated, in addition to having had a night 
of sleep.  Though unclear from these data, acceptability among women decreased after 
remaining in the jail after 7 days, perhaps explained by the impact of peer pressure and/or 
recognition of potential stigma from HIV testing.  Despite acceptability being slightly 
lower among those women approached for testing one week post-entry, a higher 
proportion consented than found in voluntary HIV testing programs in other correctional 
settings.[39-40]   
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In the women‟s trial, the most common reasons for not being swabbed for HIV 
testing included early release from the facility (presumably due to posting bond), failing 
to demonstrate medical competency to consent to testing, and choosing not to be HIV 
tested.  On multivariate analysis, additional factors significantly associated with receiving 
HIV testing were younger age (conferring a 7% decrease in the likelihood of testing for 
every ten years of increasing age) and having bond set above $5,000 (conferring nearly a 
2-fold reduced likelihood of being released).  Ability or willingness to test was 
particularly important for testing in the „immediate‟ group.  Although almost a third of 
individuals assigned to „immediate‟ testing refused testing (Figure 2), only 7% of those 
approached one day later chose to opt-out.    Those assigned to the „immediate‟ testing 
group were also 3-times more likely than either of the other groups to be medically or 
psychologically unable to consent to testing. One potential explanation for the higher rate 
of testing in the „early‟ testing group, particularly compared to the immediate group, is 
that women may have gotten some rest, been initiated on medication-assisted protocols to 
treat opioid or alcohol withdrawal, or had become resigned to being in jail.    
It was clear that the high-risk women approached for testing in this trial had not been 
adequately reached with HIV testing services.  While 89% of those who consented to 
study participation reported being previously tested for HIV, only 30% had received an 
HIV test within the last year, per CDC recommendations for high-risk individuals.   
 A major strength of the present study design was that it enabled us to accurately 
assess realistic acceptance for HIV testing in an ethical manner.  Socially marginalized 
individuals, such as prisoners, may be leery about participating in research in coercive 
places like jails. [2, 41]  We overcame this obstacle by asking jail-based clinicians to ask 
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individuals to provide verbal consent to be HIV tested before referring them to research 
personnel to obtain written consent for study participation.  Thus, this trial simulated 
what routine opt-out HIV testing within a clinical encounter in jail might look like and 
avoids biasing participant response during the encounter.  Indeed, approximately 22% of 
those female subjects who agreed to be swabbed for rapid HIV testing as part of routine 
intake procedures later refused to provide consent for study participation.  In most cases, 
this was because of subjects‟ suspicion of being involved in research or because of the 
time involved in completing several interview instruments at a time when they were tired 
or did not feel well.   The primary outcome of being swabbed for an HIV test, therefore, 
served as a better marker in this trial for acceptance of HIV testing than completion of the 
informed consent aspect of the study and thereby receiving an HIV test result. 
In addition, a key factor contributing to the higher rate of routine opt-out HIV testing 
within the first 24 hours of admission was that the testing procedures were linked to a 
routine clinical activity (intake or physical exam) with clinical personnel.  This policy, of 
linking routine opt-out HIV testing with routine clinical activities, makes logistical sense 
and should be considered when implementing testing in the future.  It also helps to 
demonstrate to inmates that HIV testing is simply a component of comprehensive 
primary healthcare.  Future observational and controlled studies should assess which staff 
members should perform testing and delivery of both positive and negative HIV test 
results during the chaotic post-entry period.  Our study did not assess this fully; we 
utilized jail staff for intake, testing, and follow-up of positive HIV test results, while all 
our own research staff provided negative results. 
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Although both trials successfully demonstrated the feasibility of routine opt-out HIV 
testing in a jail, challenges remain to be addressed before routine opt-out HIV testing is 
implemented more widely in other jail settings. Daunting challenges remain to implement 
routine opt-out HIV testing upon intake at some of the largest and busiest jails. Several 
hundred people may be processed daily, with intake procedures taking place 24 hours a 
day.  
One of the unresolved issues for routine opt-out HIV testing in jails is ensuring 
delivery of confirmatory HIV test results for those who test preliminarily-positive. In the 
women‟s trial, only two (0.6%) of the 323 women approached for testing received a 
preliminary-positive test result that required a confirmatory blood draw, the results of 
which often require up to a week to receive. Similarly, in the men‟s trial, only one 
individual was released prior to receiving his negative test result, and both individuals 
who tested preliminarily positive were incarcerated at 7 days to receive their final test 
results.  Although individuals in both trials were still incarcerated in the facility and 
therefore able to receive their confirmatory blood draw results a week later, there will be 
cases of release prior to receipt of results.  Indeed, over one-quarter of the inmates in the 
women‟s trial were released within seven days of entry.  Delivery of test results, 
particularly for individuals who have blood drawn for confirmatory testing, will prove 
difficult among this transient population.  If routine opt-out HIV testing is to be broadly 
implemented in our nation‟s jails, however, delivery of test results will remain an 
important issue and requires further resolution. While we await more rapid, confirmatory 
testing technology, Western Blot testing remains the accepted standard.    Logistical 
issues of providing results in the jail will therefore be incumbent on correctional 
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authorities to resolve, yet public health infrastructure must be maintained to address case 
finding and delivery of results to those who leave before HIV testing results are available.  
As is typical of many urban jails in the United States, the study site for the men‟s trial 
houses a population with rapid turnover.  Nearly a fifth of new admissions were released 
by the next day, with 29% no longer remaining in the facility within a week.  This raises 
significant questions about the current policy in Connecticut of requiring HIV testing 
only on those inmates with at least 90 days since their last HIV risk behavior.  Continuing 
such a policy would result in nearly three quarters of jail detainees being ineligible for 
HIV testing because they would already be released.   
An additional important finding was in both the men‟s and women‟s trials, those 
having a low likelihood for release were more likely to consent to testing, regardless of 
group assignment.  This suggests that, in jail systems with high volumes that preclude 
testing of all inmates at entry, triage systems could be useful in focusing initial testing 
efforts on those inmates for whom early release is more likely.  While the men‟s study 
did diagnose one new individual with HIV, it likely missed many other high risk 
individuals who left the facility before being offered testing as part of their assigned 
testing group.  
 There are several important limitations of the present trials.  Owing to logistical 
difficulties, we could not undertake a true randomized trial.  This makes it possible that 
confounders, such as cohort effects from particular peer leaders‟ influence on testing 
uptake, biased our results (internal validity). Our large sample size and final effect size 
suggests, however, that the differences detected here were real.  Additionally, since our 
trials were restricted to a single female and male correctional facility, the findings may 
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not be generalizable to other jail settings (external validity).Not all jails provide routine 
clinical assessments the day following admission, and others may not provide any routine 
healthcare services at all.[42]   Furthermore, large, metropolitan correctional facilities 
experiencing many-fold higher daily admissions may face additional logistical challenges 
in implementing testing as part of intake procedures.   
In conclusion, our study confirms that routine opt-out HIV testing in a jail setting is 
feasible and that early testing will likely result in the largest number of individuals being 
tested.  This approach balances the medical and psychiatric instability seen among those 
immediately upon incarceration with the high attrition rate demonstrated by those tested 7 
days later.  Early testing also results in testing a larger proportion of those who have 
never been within the correctional system before and have previously received an HIV 
test.  Such programs, if implemented properly, will result in identifying individuals with 
HIV who do not know they are infected and increase their likelihood of reducing their 
HIV risk behaviors and increasing their access to HIV treatment and prevention services. 
Notwithstanding the merits of answering the logistical question of when to HIV test, 
many other questions remain, including how to avoid repeat testing, costs associated with 
increased HIV testing and barriers associated with written informed consent. 
 
 
 
 
 
 
28 
 
 
References 
1. Warren, J., One in 100: Behind Bars in America 2008. 2008, The Pew Center on 
the States Public Safety Performance Project: Washington, DC. 
2. Sabol, W., T. Minton, and P. Harrison, Prison and Jail Inmates at Midyear 2006; 
U.S. Department of Justice Bureau of Justice Statistics, in Special Report. 2007: 
Washington, D.C. 
3. The Health Status of Soon-to-be-released Inmates: A Report to Congress., 
National Commission on Correctional Healthcare (NCCH), 2002: Washington, 
D.C. 
4. Sabin, K.M., et al., Characteristics and trends of newly identified HIV infections 
among incarcerated populations: CDC HIV voluntary counseling, testing, and 
referral system, 1992-1998. J Urban Health, 2001. 78(2): p. 241-55. 
5. Hammett, T.M., M.P. Harmon, and W. Rhodes, The burden of infectious disease 
among inmates of and releasees from US correctional facilities, 1997. Am J 
Public Health, 2002. 92(11): p. 1789-94. 
6. Nation's capital implements new jail HIV testing. AIDS Policy Law, 2006. 
21(15): p. 9. 
7. Springer, S.A. and F.L. Altice, Managing HIV/AIDS in correctional settings. Curr 
HIV/AIDS Rep, 2005. 2(4): p. 165-70. 
8. Altice, F.L., F. Mostashari, and G.H. Friedland, Trust and the acceptance of and 
adherence to antiretroviral therapy. J Acquir Immune Defic Syndr, 2001. 28(1): 
p. 47-58. 
9. Altice, F.L., et al., Predictors of HIV infection among newly sentenced male 
prisoners. J Acquir Immune Defic Syndr Hum Retrovirol, 1998. 18(5): p. 444-53. 
10. Branson, B.M., et al., Revised recommendations for HIV testing of adults, 
adolescents, and pregnant women in health-care settings. MMWR Recomm Rep, 
2006. 55(RR-14): p. 1-17; quiz CE1-4. 
11. Wolf, L.L. and R.P. Walensky, Testing for HIV Infection in the United States. 
Curr Infect Dis Rep, 2007. 9(1): p. 76-82. 
12. Altice, F.L., et al., Correlates of HIV infection among incarcerated women: 
implications for improving detection of HIV infection. J Urban Health, 2005. 
82(2): p. 312-26. 
13. Paltiel, A.D., et al., Expanded HIV screening in the United States: effect on 
clinical outcomes, HIV transmission, and costs. Ann Intern Med, 2006. 145(11): 
p. 797-806. 
14. Varghese, B. and T.A. Peterman, Cost-effectiveness of HIV counseling and testing 
in US prisons. J Urban Health, 2001. 78(2): p. 304-12. 
15. Fazel, S. and S. Lubbe, Prevalence and characteristics of mental disorders in jails 
and prisons. Curr Opin Psychiatry, 2005. 18(5): p. 550-4. 
16. Maruschak, L., HIV in Prisons and Jails, 2002. Bureau of Justice Statistics 
Bulletin. December 2004. 
29 
 
17. Maruschak, L., HIV in Prisons, 2004. Bureau of Justice Statistics Bulletin. 
November 2006. 
18. Centers for Disease Control and Prevention (U.S.). Quality assurance guidelines 
for testing using the OraQuick rapid HIV-1 antibody test. [Main rept.: 
App.:] 2003; Available from: http://purl.access.gpo.gov/GPO/LPS32161 
http://purl.access.gpo.gov/GPO/LPS32163  
19. Paltiel, A.D., et al., Expanded screening for HIV in the United States--an analysis 
of cost-effectiveness. N Engl J Med, 2005. 352(6): p. 586-95. 
20. Varghese, B., T.A. Peterman, and D.R. Holtgrave, Cost-effectiveness of 
counseling and testing and partner notification: a decision analysis. Aids, 1999. 
13(13): p. 1745-51. 
21. Basu, S., et al., HIV testing in correctional institutions: evaluating existing 
strategies, setting new standards. AIDS Public Policy J, 2005. 20(1-2): p. 3-24. 
22. Maruschak, L., Medical Problems of Jail Inmates. Bureau of Justice Statistics 
Bulletin. November 2006. 
23. HIV testing in correctional settings. HIV Inside, 2003. 5(1): p. 1-11. 
24. Kendrick, S.R., et al., Comparison of point-of-care rapid HIV testing in three 
clinical venues. Aids, 2004. 18(16): p. 2208-10. 
25. Beckwith, C.G., et al., Feasibility and acceptability of rapid HIV testing in jail. 
AIDS Patient Care STDS, 2007. 21(1): p. 41-7. 
26. Spaulding, A., et al., Enhancing Linkages to HIV in Primary Care in Jail Settings. 
http://www.chip.sph.emory.edu/documents/ConsultancyReport_update012907.pdf
, last accessed August 8,2009. 2007. 
27. Frottier, P., et al., Jailhouse Blues revisited. Soc Psychiatry Psychiatr Epidemiol, 
2002. 37(2): p. 68-73. 
28. Felthous, A.R., Preventing jailhouse suicides. Bull Am Acad Psychiatry Law, 
1994. 22(4): p. 477-88. 
29. Mumola, C.J. and United States. Office of Justice Programs. Suicide and 
homicide in state prisons and local jails.  2005; Available from: 
http://purl.access.gpo.gov/GPO/LPS68364  
30. Kim, S., et al., Deaths in the Cook County jail: 10-year report, 1995-2004. J 
Urban Health, 2007. 84(1): p. 70-84. 
31. Teplin, L.A., Psychiatric and substance abuse disorders among male urban jail 
detainees. Am J Public Health, 1994. 84(2): p. 290-3. 
32. Teplin, L.A., K.M. Abram, and G.M. McClelland, Prevalence of psychiatric 
disorders among incarcerated women. I. Pretrial jail detainees. Arch Gen 
Psychiatry, 1996. 53(6): p. 505-12. 
33. MacGowan, R. Rapid HIV Testing in Jails. in American Correctional Health 
Services Association National Meeting. 2006. Durham NC. 
34. Appelbaum, P.S. and T. Grisso, The MacArthur Competence Assessment Tool-
Clinical Research. 1996, Sarasota, FL: Professional Resource Press. 
35. Greenwald, J.L., et al., A rapid review of rapid HIV antibody tests. Curr Infect Dis 
Rep, 2006. 8(2): p. 125-31. 
36. Wesson, D.R. and W. Ling, The Clinical Opiate Withdrawal Scale (COWS). J 
Psychoactive Drugs, 2003. 35(2): p. 253-9. 
30 
 
37. Puz, C.A. and S.J. Stokes, Alcohol withdrawal syndrome: assessment and 
treatment with the use of the Clinical Institute Withdrawal Assessment for 
Alcohol-revised. Crit Care Nurs Clin North Am, 2005. 17(3): p. 297-304. 
38. Kessler, R.C., et al., Screening for serious mental illness in the general 
population. Arch Gen Psychiatry, 2003. 60(2): p. 184-9. 
39. Macgowan, R., et al., Voluntary Rapid Human Immunodeficiency Virus (HIV) 
Testing in Jails. Sexually Transmitted Diseases, 2009. 36(2): p. S9-S13. 
40. Liddicoat, R.V., et al., Implementing a routine, voluntary HIV testing program in 
a Massachusetts county prison. J Urban Health, 2006. 83(6): p. 1127-31. 
41. Wynia, M.K. and V.N. Gamble, Mistrust among minorities and the 
trustworthiness of medicine. PLoS Med, 2006. 3(5): p. e244. 
42. Wilper, A.P., et al., The health and health care of US prisoners: results of a 
nationwide survey. Am J Public Health, 2009. 99(4): p. 666-72. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
 
Figure References  
 
 
Figure 1. [Women’s Trial] Disposition of Inmates Approached for HIV Testing 
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Group 
 
Figure 3: [Women’s Trial] Time to Release Following Incarceration 
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Figure 5. [Men’s Trial] Rapid HIV Testing Swab Results by Assigned Testing  
Group 
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Figure 1. [Women’s Trial] Disposition of Inmates Approached for HIV Testing 
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Figure 2. [Women’s Trial] Rapid HIV Testing Swab Results by Assigned Testing 
Group 
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Figure 3: [Women’s Trial] Time to Release Following Incarceration 
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Figure 4. [Men’s Trial] Disposition of Inmates Approached for HIV Testing 
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Figure 5. [Men’s Trial] Rapid HIV Testing Swab Results by Assigned Testing  
Group 
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Figure 6. [Men’s Trial] Reasons Inmates were not Swabbed for HIV Testing 
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Figure 7. [Men’s Trial] Time to Release Following Incarceration 
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Table 1: [Women’s Trial] Baseline Characteristics of the Study Population (n=323) 
 
Characteristics Subcategory Value (%) 
Age (mean years; SD)  33.6 (9.8) 
Length of Current Incarceration 
(median days; IQR) 
 28 (7-94) 
Race Hispanic 53 (16) 
 Black 104 (32) 
 White/Other 166 (51) 
Education High School Graduate 201 (62%) 
 Not a High School Graduate 122 (38%) 
Likelihood of Early Release* High 115 (36) 
 Low 208 (64) 
Type of Charge Drug- or Prostitution-Related 81 (25) 
 Not Drug- or Prostitution-Related 242 (75) 
Previous Incarcerations Never Incarcerated 117 (36) 
 Incarcerated Previously 206 (64) 
 Mean Number of Previous Incarcerations (N; SD) 1.9 (2.4) 
Medical Insurance Yes 120 (37) 
 No 203 (63) 
Urine Toxicology Negative for Opiates 242 (75) 
 Positive for Opiates 81 (25) 
    * High: any charges directly related to prostitution or drugs.  
    Low: bond value  $5000, bond sentencing > 30 days, immigration or federal 
charges, or    
    no bond 
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Table 2.  [Women’s Trial] Reasons Inmates were not Swabbed for HIV Testing 
 
Reason Immediate Group Early Group Delayed Group 
 (49 not swabbed of 108) (29 not swabbed of 108) (53 not swabbed of 107) 
Bonded/Released/At Court, n (%) 4 (8) 17 (59) 36 (68) 
Refused/Declined Swab or Study Participation, n (%) 33 (67) 8 (27) 13 (24) 
Medically Incompetent/Failed MacArthur, n (%) 12 (25) 4 (14) 4 (8) 
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Table 3. [Women’s Trial] Bivariable and Multivariable Predictors of Receipt of 
Swab 
 
 Uptake 
Rates, n (%) 
Bivariable 
OR (95% CI) 
Bivariable 
p-value 
Multivariable 
OR (95% CI) 
Multivariable 
p-value 
Assigned day 0* 59 (55) 1.2 (0.7 to 2) 0.54 
1.2 (0.7 to 
2.1) 
0.51 
Assigned day 1* 79 (73) 
2.7 (1.5 to 
4.7) 
0.0007 2.7 (1.5 to 5) 0.0009 
Assigned day 7* 54 (50) --Referrent-- -- --Referrent-- -- 
      
Age (yrs) at Entry** -- 
0.7 (0.6 to 
0.9) 
0.01 
0.7 (0.6 to 
0.9) 
0.01 
      
Low Likelihood of 
Release 
133 (64) 
1.7 (1.1 to 
2.7) 
0.03 
1.9 (1.1 to 
3.1) 
0.01 
High Likelihood of 
Release 
59 (51) --Referrent-- -- --Referrent-- -- 
      
High HIV-Risk 
Offense 
56 (69) 1.7 (1 to 3) 0.04 1.7 (1 to 3) 0.07 
Low HIV-Risk 
Offense 
136 (56) --Referrent-- -- --Referrent-- -- 
      
Black 55 (53) 
0.7 (0.4 to 
1.1) 
0.10 
0.7 (0.4 to 
1.2) 
0.17 
Hispanic 40 (75) 
2.4 (1.2 to 
4.7) 
0.01 2 (1 to 4.1) 0.07 
White/Other 97 (58) --Referrent-- -- --Referrent-- -- 
      
Previous 
Incarceration 
125 (61) 
1.2 (0.7 to 
1.8) 
0.55 
-Out of 
Model- 
-- 
No Previous 
Incarceration 
67 (57) --Referrent-- -- 
-Out of 
Model- 
-- 
      
Urine Opiate(+) 51 (63) 1.2 (0.7 to 2) 0.46 
-Out of 
Model- 
-- 
Urine Opiate(-) 141(58) --Referrent-- -- 
-Out of 
Model- 
-- 
      
High School 
Graduate 
118 (59) 
0.92 (0.6 to 
1.5) 
0.73 
-Out of 
Model- 
-- 
Not High School 
Graduate 
74 (61) --Referrent-- -- 
-Out of 
Model- 
-- 
      
Has Medical 
Insurance 
66 (55) 
0.7 (0.5 to 
1.2) 
0.21 
-Out of 
Model- 
-- 
No Medical 
Insurance 
126 (62) --Referrent-- -- 
-Out of 
Model- 
-- 
 
*OR Comparing day 1 or day 7, respectively to day 0. 
**The calculated OR represents the added likelihood conferred by every 10 years of age 
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Table 4: [Men’s Trial] Baseline Characteristics of the Study Population (n=298) 
 
Characteristics Subcategory Value (%) 
Age (mean years; SD)  35 (11) 
Ethnicity Hispanic 56 (19) 
 Black 104 (35) 
 White/Other 138 (46) 
High School Graduate Yes 193 (65) 
 No 105 (35) 
Length of Current Incarceration 
(median days; IQR) 
 28 (4-36) 
High Likelihood of Early 
Release* 
Yes 122 (41) 
 No 176 (59) 
Drug- or Prostitution-Related 
Offense 
Yes 46 (15) 
 No 252 (85) 
Previous History of Incarceration Yes 244 (82) 
 No 54 (18) 
Has Medical Insurance Yes 276 (93) 
 No 22 (7) 
* High: any charges directly related to prostitution or drugs.  
Low: bond value  $5000, bond sentencing > 30 days, immigration or federal charges, or 
no bond 
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Table 5. [Men’s Trial] Bivariable and Multivariable Predictors of Receipt of Swab 
 
 Uptake 
Rates, n (%) 
Bivariable 
OR (95% CI) 
Bivariable 
p-value 
Multivariable 
OR (95% CI) 
Multivariable 
p-value 
Assigned day 0* 55 (53) 
2.3 (1.26 to 
4) 
0.01 
2.4 (1.4 to 
4.3) 
0.00 
Assigned day 1* 56 (57) 
2.6 (1.5 to 
4.7) 
0.0013 
3.0 (1.7 to 
5.6) 
0.0003 
Assigned day 7* 33 (34) --Referrent-- -- --Referrent-- -- 
      
Low Likelihood of 
Release 
52 (43) 
0.7 (0.5 to 
1.1) 
0.10 
0.1 (0.1 to 
0.7) 
0.04 
High Likelihood of 
Release 
92 (52) --Referrent-- -- --Referrent-- -- 
      
High School 
Graduate 
88 (46) 
0.74 (0.5 to 
1.2) 
0.20 
0.8 (0.5 to 
1.2) 
0.21 
Not High School 
Graduate 
56 (53) --Referrent-- -- --Referrent-- -- 
      
Has Medical 
Insurance 
131 (47) 
1.6 (0.7 to 
3.9) 
0.30 2 (0.8 to 5.1) 0.15 
No Medical 
Insurance 
13 (59) --Referrent-- -- --Referrent-- -- 
      
Age (years) at 
Entry** 
-- 
0.9 (0.72 to 
1.12) 
0.32 
-Out of 
Model- 
-- 
      
Low HIV-Risk 
Offense 
18 (39) --Referrent-- -- 
-Out of 
Model- 
-- 
High HIV-Risk 
Offense 
126 (50) 
0.7 (0.4 to 
1.3) 
0.18 
-Out of 
Model- 
-- 
      
White/Other 49 (47) --Referrent-- -- 
-Out of 
Model- 
-- 
Black 29 (52) 1 (0.6 to 1.5) 0.73 
-Out of 
Model- 
-- 
Hispanic 66 (48) 
1.2 (0.7 to 
2.2) 
0.58 
-Out of 
Model- 
-- 
      
No Previous 
Incarceration 
23 (43) --Referrent-- -- 
-Out of 
Model- 
-- 
Previous 
Incarceration 
121 (50) 
1.4 (0.8 to 
2.5) 
0.35 
-Out of 
Model- 
-- 
 
*OR Comparing day 1 or day 7, respectively to day 0. 
**The calculated OR represents the added likelihood conferred by every 10 years of age 
 
